EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC)

Lung Cancer

Volumn 86, Issue 2, 2014, Pages 158-163

  Reynolds, Jordan P ^a   Tubbs, Raymond R ^a   Minca, Eugen C ^a   MacNamara, Stephen ^a,d   Almeida, Francisco A ^b   Ma, Patrick C ^c   Pennell, Nathan A ^c   Cicenia, Joseph C ^b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d Abbott Molecular Inc   (United States)

Author keywords

Endobronchial ultrasound guided fine needle aspiration; Epidermal growth factor receptor; Fine needle aspiration; Lung cancer; Non small cell lung carcinoma; Targeted therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADVANCED CANCER; ARTICLE; ASPIRATION CYTOLOGY; BIOPSY; ENDOBRONCHIAL ULTRASONOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; IMAGE GUIDED BIOPSY; LUNG BIOPSY; NON SMALL CELL LUNG CANCER; SENSITIVITY AND SPECIFICITY; TUMOR CELL; ALLELE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSCOPIC ECHOGRAPHY; EXON; GENE FREQUENCY; GENETICS; LUNG NEOPLASMS; MUTATION; REPRODUCIBILITY;

ALLELES; BIOPSY, FINE-NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOSONOGRAPHY; EXONS; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; LUNG NEOPLASMS; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84908404380     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.09.003     Document Type: Article

References (34)

1. Ciardiello F., Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008, 358:1160-1174.
2. Kobayashi S., Boggon T.J., Dayaram T., Janne P.A., Kocher O., Meyerson M., Johnson B.E., Eck M.J., Tenen D.G., Halmos B. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 2005, 352:786-792.
3. Kwak E.L., Bang Y.J., Camidge D.R., Shaw A.T., Solomon B., Maki R.G., Ou S.H., Dezube B.J., Janne P.A., Costa D.B., Varella-Garcia M., Kim W.H., Lynch T.J., Fidias P., Stubbs H., Engelman J.A., Sequist L.V., Tan W., Gandhi L., Mino-Kenudson M., Wei G.C., Shreeve S.M., Ratain M.J., Settleman J., Christensen J.G., Haber D.A., Wilner K., Salgia R., Shapiro G.I., Clark J.W., Iafrate A.J. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010, 363:1693-1703.
4. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., Louis D.N., Christiani D.C., Settleman J., Haber D.A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
5. Masago K., Fujita S., Irisa K., Kim Y.H., Ichikawa M., Mio T., Mishima M. Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC>ATC in exon 20 (S768I). Jpn J Clin Oncol 2010, 40:1105-1109.
6. Mukohara T., Engelman J.A., Hanna N.H., Yeap B.Y., Kobayashi S., Lindeman N., Halmos B., Pearlberg J., Tsuchihashi Z., Cantley L.C., Tenen D.G., Johnson B.E., Janne P.A. Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst 2005, 97:1185-1194.
7. Nakano H., Soda H., Nakamura Y., Uchida K., Takasu M., Nakatomi K., Izumikawa K., Hayashi T., Nagayasu T., Tsukamoto K., Kohno S. Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers. Clin Lung Cancer 2007, 8:562-564.
8. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., Naoki K., Sasaki H., Fujii Y., Eck M.J., Sellers W.R., Johnson B.E., Meyerson M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
9. Pao W., Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 2010, 10:760-774.
10. Pao W., Miller V.A., Politi K.A., Riely G.J., Somwar R., Zakowski M.F., Kris M.G., Varmus H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005, 2:e73.
11. Lindeman N.I., Cagle P.T., Beasley M.B., Chitale D.A., Dacic S., Giaccone G., Jenkins R.B., Kwiatkowski D.J., Saldivar J.S., Squire J., Thunnissen E., Ladanyi M. College of American Pathologists International Association for the Study of Lung C, Association for Molecular P. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Mol Diagn 2013, 15:415-453.
12. Karunamurthy A., Cai G., Dacic S., Khalbuss W.E., Pantanowitz L., Monaco S.E. Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): correlation with adequacy and histologic follow-up. Cancer Cytopathol 2014, 122:23-32.
13. Odronic S.I., Gildea T.R., Chute D.J. Electromagnetic navigation bronchoscopy-guided fine needle aspiration for the diagnosis of lung lesions. Diagn Cytopathol 2014, epub ahead of print.
14. Ha D., Choi H., Almeida F.A., Arrossi A., Brainard J., Cicenia J., Farver C., Gildea T., Machuzak M.S., Mazzone P. Histologic and molecular characterization of lung cancer with tissue obtained by electromagnetic navigation bronchoscopy. J Bronchol Interv Pulmonol 2013, 20:10-15.
15. Almeida F.A. Bronchoscopy and endobronchial ultrasound for diagnosis and staging of lung cancer. Cleve Clin J Med 2012, 79(Electronic Suppl 1):eS11-eS16.
16. Almeida F.A., Casal R.F., Jimenez C.A., Eapen G.A., Uzbeck M., Sarkiss M., Rice D., Morice R.C., Ost D.E. Quality gaps and comparative effectiveness in lung cancer staging: the impact of test sequencing on outcomes. Chest 2013, 144:1776-1782.
17. Kokkonouzis I., Strimpakos A.S., Lampaditis I., Tsimpoukis S., Syrigos K.N. The role of endobronchial ultrasound in lung cancer diagnosis and staging: a comprehensive review. Clin Lung Cancer 2012, 13:408-415.
18. Macabeo-Ong M., Ginzinger D.G., Dekker N., McMillan A., Regezi J.A., Wong D.T., Jordan R.C. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses. Mod Pathol 2002, 15:979-987.
19. Wagner D.G., Russell D.K., Benson J.M., Schneider A.E., Hoda R.S., Bonfiglio T.A. Cellient automated cell block versus traditional cell block preparation: a comparison of morphologic features and immunohistochemical staining. Diagn Cytopathol 2011, 39:730-736.
20. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., Bando M., Ohno S., Ishikawa Y., Aburatani H., Niki T., Sohara Y., Sugiyama Y., Mano H. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
21. Feller-Kopman D., Yung R.C., Burroughs F., Li Q.K. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: a retrospective study with histology correlation. Cancer 2009, 117:482-490.
22. Sun W., Song K., Zervos M., Pass H., Cangiarella J., Bizekis C., Crawford B., Wang B.Y. The diagnostic value of endobronchial ultrasound-guided needle biopsy in lung cancer and mediastinal adenopathy. Diagn Cytopathol 2010, 38:337-342.
23. Hoda R.S., Loukeris K., Abdul-Karim F.W. Gynecologic cytology on conventional and liquid-based preparations: a comprehensive review of similarities and differences. Diagn Cytopathol 2013, 41:257-278.
24. Skacel M., Fahmy M., Brainard J.A., Pettay J.D., Biscotti C.V., Liou L.S., Procop G.W., Jones J.S., Ulchaker J., Zippe C.D., Tubbs R.R. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003, 169:2101-2105.
25. Skacel M., Liou L.S., Pettay J.D., Tubbs R.R. Interphase fluorescence in-situ hybridization in the diagnosis of bladder cancer. Front Biosci 2002, 7:e27-e32.
26. Skacel M., Pettay J.D., Tsiftsakis E.K., Procop G.W., Biscotti C.V., Tubbs R.R. Validation of a multicolor interphase fluorescence in situ hybridization assay for detection of transitional cell carcinoma on fresh and archival thin-layer, liquid-based cytology slides. Anal Quant Cytol Histol 2001, 23:381-387.
27. Minca E.C., Lanigan C.P., Reynolds J.P., Wang Z., Ma P.C., Cicenia J., Almeida F.A., Pennell N.A., Tubbs R.R. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material. J Thorac Oncol 2014, 9:464-468.
28. Yung R.C., Otell S., Illei P., Clark D.P., Feller-Kopman D., Yarmus L., Askin F., Gabrielson E., Li Q.K. Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration. Cancer Cytopathol 2012, 120:185-195.
29. Folch E., Yamaguchi N., Vanderlaan P.A., Kocher O.N., Boucher D.H., Goldstein M.A., Huberman M.S., Kent M.S., Gangadharan S.P., Costa D.B., Majid A. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer. J Thorac Oncol 2013, 8:1438-1444.
30. Jain D., Mathur S.R., Iyer V.K. Cell blocks in cytopathology: a review of preparative methods, utility in diagnosis and role in ancillary studies. Cytopathology 2014, epub ahead of print.
31. Gleeson F.C., Kipp B.R., Levy M.J., Voss J.S., Campion M.B., Minot D.M., Tu Z.J., Klee E.W., Lazaridis K.N., Kerr S.E. Lung cancer adrenal gland metastasis: optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing. Cancer Cytopathol 2014, epub ahead of print.
32. Greer C.E., Wheeler C.M., Manos M.M. Sample preparation and PCR amplification from paraffin-embedded tissues. PCR Methods Appl 1994, 3:S113-S122.
33. Hagiwara K., Kobayashi K. Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer. Cancer Sci 2013, 104:291-297.
34. Liu D., Nakano J., Ueno M., Masuya D., Nakashima T., Yokomise H., Yube K., Huang C.L. A useful protocol for analyses of mutations of the epidermal growth factor receptor gene. Oncol Rep 2006, 15:1503-1505.